These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 35866202)
1. Intensive Olfactory Training in Post-COVID-19 Patients: A Multicenter Randomized Clinical Trial. Pires ÍAT; Steffens ST; Mocelin AG; Shibukawa DE; Leahy L; Saito FL; Amadeu NT; Lopes NMD; Garcia ECD; Albanese ML; De Mari LF; Ferreira IM; Veiga CA; Jebahi Y; Coifman H; Fornazieri MA; Hamerschmidt R Am J Rhinol Allergy; 2022 Nov; 36(6):780-787. PubMed ID: 35866202 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of Combined Visual-Olfactory Training With Patient-Preferred Scents as Treatment for Patients With COVID-19 Resultant Olfactory Loss: A Randomized Clinical Trial. Khan AM; Piccirillo J; Kallogjeri D; Piccirillo JF JAMA Otolaryngol Head Neck Surg; 2023 Feb; 149(2):141-149. PubMed ID: 36580304 [TBL] [Abstract][Full Text] [Related]
3. Olfactory dysfunction and training in children with COVID-19 infection: A prospective study Post-COVID pediatric olfactory training. Chan KH; Thomas BJ; Gilbert DD; Tong S; Teynor NJ; Friedman NR; Herrmann BW; Gitomer SA Int J Pediatr Otorhinolaryngol; 2024 Jan; 176():111799. PubMed ID: 38081110 [TBL] [Abstract][Full Text] [Related]
4. Stellate Ganglion Block for the Treatment of COVID-19-Induced Olfactory Dysfunction: A Prospective Pilot Study. Peterson AM; Miller BJ; Kallogjeri D; Piccirillo JF; Kukuljan S; Roland LT; Schneider JS; Crock LW; Farrell NF Otolaryngol Head Neck Surg; 2024 Jan; 170(1):272-276. PubMed ID: 37750244 [TBL] [Abstract][Full Text] [Related]
5. Effects of classical olfactory training in patients with COVID-19-related persistent loss of smell. Yaylacı A; Azak E; Önal A; Aktürk DR; Karadenizli A Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):757-763. PubMed ID: 35904631 [TBL] [Abstract][Full Text] [Related]
6. Natural trajectory of recovery of COVID-19 associated olfactory loss. Khan AM; Lee J; Rammaha T; Gupta S; Smith H; Kannampallil T; Farrell N; Kallogjeri D; Piccirillo JF Am J Otolaryngol; 2022; 43(5):103572. PubMed ID: 35969913 [TBL] [Abstract][Full Text] [Related]
7. Olfactory dysfunction in SARS-CoV-2 infection: Focus on odorant specificity and chronic persistence. Rebholz H; Pfaffeneder-Mantai F; Knoll W; Hassel AW; Frank W; Kleber C Am J Otolaryngol; 2021; 42(5):103014. PubMed ID: 33873048 [TBL] [Abstract][Full Text] [Related]
8. Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled Clinical Trial. Di Stadio A; D'Ascanio L; Vaira LA; Cantone E; De Luca P; Cingolani C; Motta G; De Riu G; Vitelli F; Spriano G; De Vincentiis M; Camaioni A; La Mantia I; Ferreli F; Brenner MJ Curr Neuropharmacol; 2022; 20(10):2001-2012. PubMed ID: 35450527 [TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Novel At-home Smell Assessment. Gupta S; Kallogjeri D; Farrell NF; Lee JJ; Smith HJ; Khan AM; Piccirillo JF JAMA Otolaryngol Head Neck Surg; 2022 Mar; 148(3):252-258. PubMed ID: 35024772 [TBL] [Abstract][Full Text] [Related]
11. The 8-Odorant Barcelona Olfactory Test (BOT-8): Validation of a New Test in the Spanish Population During the COVID-19 Pandemic. Rojas-Lechuga MJ; Ceballos JC; Valls-Mateus M; Mackers P; Izquierdo-Domínguez A; López-Chacón M; Langdon C; Mariño-Sánchez F; Valero J; Mullol J; Alobid I J Investig Allergol Clin Immunol; 2022 Jul; 32(4):291-298. PubMed ID: 35532333 [TBL] [Abstract][Full Text] [Related]
12. Platelet-rich plasma injection in the olfactory clefts of COVID-19 patients with long-term olfactory dysfunction. Lechien JR; Le Bon SD; Saussez S Eur Arch Otorhinolaryngol; 2023 May; 280(5):2351-2358. PubMed ID: 36520209 [TBL] [Abstract][Full Text] [Related]
13. Smell dysfunction: a biomarker for COVID-19. Moein ST; Hashemian SM; Mansourafshar B; Khorram-Tousi A; Tabarsi P; Doty RL Int Forum Allergy Rhinol; 2020 Aug; 10(8):944-950. PubMed ID: 32301284 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Olfactory Disorders After SARS - CoViD 2 Virus Infection. Schmidt F; Azar C; Goektas O Ear Nose Throat J; 2024 Jun; 103(1_suppl):48S-53S. PubMed ID: 36976171 [TBL] [Abstract][Full Text] [Related]
15. Olfactory-related Quality of Life Adjustments in Smell Loss during the Coronavirus-19 Pandemic. Liu DT; Prem B; Besser G; Renner B; Mueller CA Am J Rhinol Allergy; 2022 Mar; 36(2):253-260. PubMed ID: 34704454 [TBL] [Abstract][Full Text] [Related]
20. Olfactory training for olfactory dysfunction in COVID-19: A promising mitigation amidst looming neurocognitive sequelae of the pandemic. Ojha P; Dixit A Clin Exp Pharmacol Physiol; 2022 Apr; 49(4):462-473. PubMed ID: 35090056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]